Harold Bernstein, President, R&D & CMO: Maze Therapeutics MAZE Planned sale · Filed 09/04

Trade details

Type: Planned sale notice
Stock: Maze Therapeutics MAZE
Person: Harold BernsteinPresident, R&D & CMO
Planned sale date: 26/09/04
Filed: 26/09/04

More to sell after $1.6M in 3 months

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 08/05~10/04

Harold Bernstein's recent trades

Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$438.7K
16,141 sh
$438.7K
Filed 10/01
Traded 10/01
Harold BernsteinPresident, R&D & CMO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$283.5K
10,685 sh
$283.5K
Filed 09/02
Traded 09/02
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1.4M
46,892 sh
$1.4M
Filed 07/01
Traded 07/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$338.9K
13,253 sh
$338.9K
Filed 06/03
Traded 06/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$42.2K
1,600 sh
$42.2K
Filed 06/03
Traded 06/01

Harold Bernstein, CMO — plans to sell 9,705 sh of Maze Therapeutics MAZE · $251.1K · around 09/04 · 10b5-1 plan | Whalegun